Oak Harbor Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-3,276
Closed -$237K – 252
2025
Q1
$237K Sell
3,276
-4,302
-57% -$308K 0.07% 183
2024
Q4
$561K Sell
7,578
-47
-0.6% -$3.29K 0.16% 111
2024
Q3
$503K Buy
7,625
+111
+1% +$8.06K 0.14% 118
2024
Q2
$694K Buy
7,514
+341
+5% +$30.2K 0.22% 94
2024
Q1
$685K Buy
7,173
+374
+6% +$31.4K 0.21% 101
2023
Q4
$518K Sell
6,799
-129
-2% -$8.98K 0.17% 107
2023
Q3
$480K Buy
6,928
+887
+15% +$71.3K 0.17% 110
2023
Q2
$570K Sell
6,041
-176
-3% -$15.3K 0.19% 104
2023
Q1
$514K Buy
6,217
+2,711
+77% +$213K 0.19% 107
2022
Q4
$262K Sell
3,506
-1,411
-29% -$109K 0.1% 136
2022
Q3
$406K Buy
4,917
+368
+8% +$35.4K 0.16% 108
2022
Q2
$433K Buy
4,549
+1,376
+43% +$142K 0.17% 101
2022
Q1
$374K Buy
3,173
+437
+16% +$49K 0.12% 119
2021
Q4
$354K Buy
+2,736
New +$319K 0.12% 119

Other funds holding EW

Oak Harbor Wealth Partners's EW Position: Q2 2025 in Review

Oak Harbor Wealth Partners sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 3,276 shares — an estimated $237K sold.

Oak Harbor Wealth Partners first reported a position in EW in Q4 2021 and held it in 14 quarters. The position peaked at $694K in Q2 2024. 1,261 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Oak Harbor Wealth Partners reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Oak Harbor Wealth Partners sold 3,276 Edwards Lifesciences shares in Q2 2025, an estimated $237K.
  • Oak Harbor Wealth Partners first reported a position in Edwards Lifesciences in Q4 2021 and held it in 14 quarters.
  • Oak Harbor Wealth Partners's Edwards Lifesciences position peaked at $694K in Q2 2024.
  • 1,261 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Oak Harbor Wealth Partners's 13F filing for Q2 2025, filed 31 Jul 2025.